IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 4Th February 2022 And Submission Of Audited Financial Results For The Quarter And Nine Months Ended 31St December 2021.
Outcome of the Board Meeting dated 4th February 2022 and submission of Audited Financial Results for the quarter and nine months ended 31st December 2021. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Audited Financial Results For The Quarter And Nine Months Ended 31St December 2021.
Outcome of the Board Meeting dated 4th February 2022 and submission of Audited Financial Results for the quarter and nine months ended 31st December 2021. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of analyst/ investors conference call - Q3 & 9M FY22 IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in Newspapers IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board to consider Q3 results & Interim Dividend on Feb 04, 2022
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on February 04, 2022, inter, alia, to consider and approve the Audited Financial Results of the Company for the Quarter and nine months ended December 31, 2021 and declaration of Interim Dividend, if any, for the Financial Year 2021-2022.Further, pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s "Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons", the Trading Window which is closed with effect from January 01, 2022 shall continue to close till the expiry of 48 hours from the date of financial results for Quarterand nine months ended December 31, 2021 are made public. Accordingly, the trading window shall reopen on February 07, 2022. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Intimation for Notice Of The Board Meeting
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 ,inter alia, to consider and approve approve the Audited Financial Results of the Company for the Quarter and nine months ended 31st December 2021 and declaration of Interim Dividend, if any, for the Financial Year 2021-2022. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Shareholding for the Period Ended December 31, 2021
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of duplicate share certificates IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Abhay Raj SinghDesignation :- Company Secretary and Compliance Officer